Successful Prevention of Recurrent Ventricular Fibrillation by Intravenous Isoproterenol in a Patient with Brugada Syndrome

TANAKA, H., et al.: Successful Prevention of Recurrent Ventricular Fibrillation by Intravenous Isoproterenol in a Patient with Brugada Syndrome. Intravenous administration of isoproterenol restored the ST‐segment configuration to nearly normal in the right precordial leads and completely prevented s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pacing and clinical electrophysiology 2001-08, Vol.24 (8), p.1293-1294
Hauptverfasser: TANAKA, HIROKAZU, KINOSHITA, OSAMU, UCHIKAWA, SHINICHIROU, KASAI, HIROKI, NAKAMURA, MEGUMI, IZAWA, ATSUSHI, YOKOSEKI, OSAMU, KITABAYASHI, HIROSHI, TAKAHASHI, WATARU, YAZAKI, YOSHIKAZU, WATANABE, NOBORU, IMAMURA, HIROSHI, KUBO, KEISHI
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:TANAKA, H., et al.: Successful Prevention of Recurrent Ventricular Fibrillation by Intravenous Isoproterenol in a Patient with Brugada Syndrome. Intravenous administration of isoproterenol restored the ST‐segment configuration to nearly normal in the right precordial leads and completely prevented spontaneous VF attacks in a patient with Brugada syndrome. The formation of a Brugada‐type ECG has been attributed to the transmural dispersion of repolarization of the right ventricular epicardium and related to modulation of the autonomic nervous system. Our case may provide clues to the pathophysiological mechanism of this syndrome.
ISSN:0147-8389
1540-8159
DOI:10.1046/j.1460-9592.2001.01293.x